News

ZIODIA Co., Ltd. has been finally selected for the '2025-2026 CTS Seed 0' 2nd cohort program organized by the Korea International Cooperation Agency (KOICA).

KOICA CTS (Creative Technology Solution) Seed 0 is a program that identifies domestic early-stage startups with innovative technology solutions for addressing social challenges in developing countries and supports their systematic entry into global markets. A total of 25 teams were finally selected from early-stage startups across various domestic and international sectors for this 2nd cohort.

ZIODIA was included in this selection, recognized for the innovative technology of its Quantum Dot-based in-vitro diagnostic platform 'MadaCheck' and its potential as a point-of-care (POC) diagnostic solution suited for healthcare environments in developing countries.

Through this program, ZIODIA plans to actively utilize KOICA's ODA (Official Development Assistance) network to establish localization strategies for entering developing country markets and contribute to improving global medical accessibility.

Moving forward, ZIODIA will continue to lead improvements in global medical infrastructure based on its innovative in-vitro diagnostic technology and grow as a global healthcare company.

Source: https://news.nate.com/view/20260327n17936